Veranex, Inc.

Veranex is the industry's first fully integrated Innovation CRO (Contract Research Organization), headquartered in Raleigh, North Carolina. Founded in 2021, the company unites product design, engineering, manufacturing, preclinical research, clinical research, regulatory affairs, quality management, and market-access expertise under one roof to accelerate medical device and in vitro diagnostic (IVD) development from concept to commercialization. With over 800 cross-disciplinary specialists across 15 international hubs (including London and Bangalore), Veranex serves 700+ global clients and has accelerated 1,000+ programs. The company specializes in cardiovascular, neurovascular, ophthalmology, and diagnostic device innovation, offering integrated services including GLP/non-GLP preclinical studies, optimized clinical trial design and execution, FDA and EU-MDR regulatory strategy, ISO 13485 quality management systems, contract manufacturing with scalable volumes, and commercialization support. Veranex emphasizes patient-centric innovation, cross-disciplinary collaboration, and accountability to eliminate traditional CRO fragmentation and reduce development timelines and costs.